Anacetrapib

CAS No.:875446-37-0

TBW03897
Anacetrapib;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one;(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one;Anacetrapib (MK-0859);MK0859;MK-0859;UNII-P7T269PR6S;P7T269PR6S;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one;Anacetrapib [USAN:INN];Anacetrapib (JAN/USAN);cc-7
inquiry
C30H25F10NO3
637.51

Product introduction

Category: Natural products
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: FC(C1C([H])=C(C(F)(F)F)C([H])=C(C=1[H])[C@]1([H])[C@]([H])(C([H])([H])[H])N(C(=O)O1)C([H])([H])C1C([H])=C(C(F)(F)F)C([H])=C([H])C=1C1C(=C([H])C(=C(C([H])(C([H])([H])[H])C([H])([H])[H])C=1[H])F)OC([H])([H])[H])(F)F